First clinical trial of an automated blood drawing and testing device
In the future, robots could take blood samples, benefiting patients and healthcare workers alike.
A Rutgers-led team has created a blood-sampling robot that performed as well or better than people, according to the first human clinical trial of an automated blood drawing and testing device.
The device provides quick results and would allow healthcare professionals to spend more time treating patients in hospitals and other settings.
The results, published in the journal Technology, were comparable to or exceeded clinical standards, with an overall success rate of 87% for the 31 participants whose blood was drawn. For the 25 people whose veins were easy to access, the success rate was 97%.
The device includes an ultrasound image-guided robot that draws blood from veins. A fully integrated device, which includes a module that handles samples and a centrifuge-based blood analyzer, could be used at bedsides and in ambulances, emergency rooms, clinics, doctors’ offices and hospitals.
Venipuncture, which involves inserting a needle into a vein to get a blood sample or perform IV therapy, is the world’s most common clinical procedure, with more than 1.4 billion performed yearly in the United States. But clinicians fail in 27% of patients without visible veins, 40% of patients without palpable veins and 60% of emaciated patients, according to previous studies.
Repeated failures to start an IV line boost the likelihood of phlebitis, thrombosis and infections, and may require targeting large veins in the body or arteries – at much greater cost and risk. As a result, venipuncture is among the leading causes of injury to patients and clinicians. Moreover, a hard time accessing veins can increase procedure time by up to an hour, requires more staff and costs more than $4 billion a year in the United States, according to estimates.
“A device like ours could help clinicians get blood samples quickly, safely and reliably, preventing unnecessary complications and pain in patients from multiple needle insertion attempts,” said lead author Josh Leipheimer, a biomedical engineering doctoral student in the Yarmush lab in the biomedical engineering department in the School of Engineering at Rutgers University–New Brunswick.
In the future, the device could be used in such procedures as IV catheterization, central venous access, dialysis and placing arterial lines. Next steps include refining the device to improve success rates in patients with difficult veins to access. Data from this study will be used to enhance artificial intelligence in the robot to improve its performance.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Blood-sampling robot
- BGI Genomics’ First African Public Health Initiative: Supporting Cervical Cancer Screening for 20,000 Rwandans
On April 30, BGI Genomics and the Rwanda Biomedical Centre (RBC) launched a cervical cancer screening program in Ngoma District, Eastern Province, Rwanda. This program will provide 20,000 Human ...
- Dutch startup to bring robotic blood drawing to hospitals
Since 2023, Vitestro is running the world’s largest-scale clinical trial for autonomous blood drawing devices in collaboration with hospitals and medical centres in the Netherlands.
- Autonomous blood drawing device developer Vitestro raises $22M
Autonomous blood drawing company Vitestro believes the answer to that lies in robotics.
- How to recruit Curie in Fallout 4
Fallout 4 a trail that leads uphill from Chestnut Hillock Reservoir locked room ...
- New on Netflix in May 2024 — all the new shows and movies to watch
May 2024 offers a sizeable slate of new Netflix movies and shows including "Bridgerton" season 3, "Atlas" and more.
Go deeper with Google Headlines on:
Blood-sampling robot
[google_news title=”” keyword=”blood-sampling robot” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Automated blood drawing and testing
- Khosla, VCs Plow $100 Million Into Blood Test Startup Using AI
Blood-testing company Karius Inc. raised $100 million in a new funding round from investors, and will use the cash to get its technology for detecting hard-to-identify infections into more hospitals.
- Could blood tests make early stage cancer diagnosis accessible?
A U.S. company is developing a blood test to detect 18 types of cancers. But there is still work ahead to prove its value.
- Artificial intelligence could help diagnose cancer with one spot of dried blood
Scientists in China have created a test using artificial intelligence that can detect cancer using one spot of dried blood.
- Dutch startup to bring robotic blood drawing to hospitals
Since 2023, Vitestro is running the world’s largest-scale clinical trial for autonomous blood drawing devices in collaboration with hospitals and medical centres in the Netherlands.
- A blood test for stroke risk? Biomarker for risk of future cerebrovascular disease
A simple blood test could allow doctors to determine whether a person may be at higher risk for stroke or cognitive decline during their lifetime, according to a new study. A simple blood test could ...
Go deeper with Google Headlines on:
Automated blood drawing and testing
[google_news title=”” keyword=”automated blood drawing and testing” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]